Q1 2023 Holdings
Filed 2023-05-15 | 41 holdings | $6.7B | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Horizon Therapeutics PLC | Common | G46188101 | $764.0M | 7,000,000 | 11.3% |
| Apellis Pharmaceuticals Inc(APLS) | Common | 03753U106 | $732.9M | 11,111,111 | 10.9% |
| United Therapeutics Corp(UTHR) | Common | 91307C102 | $642.8M | 2,870,000 | 9.5% |
| Sarepta Therapeutics Inc(SRPT) | Common | 803607100 | $503.1M | 3,650,000 | 7.5% |
| Argenx SE(ARGX) | Sponsored ADR | 04016X101 | $479.7M | 1,287,500 | 7.1% |
| Madrigal Pharmaceuticals Inc(MDGL) | Common | 558868105 | $403.8M | 1,666,666 | 6.0% |
| Biomarin Pharmaceutical Inc(BMRN) | Common | 09061G101 | $383.6M | 3,945,000 | 5.7% |
| Seagen Inc(SGENUSD) | Common | 81181C104 | $364.8M | 1,801,906 | 5.4% |
| Ascendis Pharma(ASND) | Sponsored ADR | 04351P101 | $356.5M | 3,325,000 | 5.3% |
| Amicus Therapeutics Inc(FOLD) | Common | 03152W109 | $302.8M | 27,300,000 | 4.5% |
| Alnylam Pharmaceuticals Inc(ALNY) | Common | 02043Q107 | $221.4M | 1,105,000 | 3.3% |
| Mirati Therapeutics Inc(MRTXEUR) | Common | 60468T105 | $206.6M | 5,555,555 | 3.1% |
| Xenon Pharmaceuticals Inc(XENE) | Common | 98420N105 | $175.4M | 4,900,000 | 2.6% |
| Iveric BIO Inc(OPHTEUR) | Common | 46583P102 | $165.4M | 6,800,000 | 2.5% |
| Krystal Biotech Inc(KRYS) | Common | 501147102 | $140.1M | 1,750,000 | 2.1% |
| Kymera Therapeutics Inc(KYMR) | Common | 501575104 | $114.2M | 3,855,000 | 1.7% |
| Dice Therapeutics Inc | Common | 23345J104 | $113.2M | 3,950,000 | 1.7% |
| Cymabay Therapeutics Inc(CBAYUSD) | Common | 23257D103 | $89.8M | 10,300,000 | 1.3% |
| Biocryst Pharmaceuticals Inc(BCRX) | Common | 09058V103 | $86.9M | 10,420,000 | 1.3% |
| Syndax Pharmaceuticals Inc(SNDX) | Common | 87164F105 | $56.0M | 2,650,000 | 0.8% |
| Nuvalent Inc(NUVL) | Common | 670703107 | $49.3M | 1,888,888 | 0.7% |
| Iovance Biotherapeutics Inc(IOVA) | Common | 462260100 | $42.9M | 7,020,000 | 0.6% |
| Avidity Biosciences Inc(RNA) | Common | 05370A108 | $38.5M | 2,510,000 | 0.6% |
| Kura Oncology Inc(KURA) | Common | 50127T109 | $38.0M | 3,105,000 | 0.6% |
| Mannkind Corp(MNKD) | Common | 56400P706 | $37.3M | 9,100,000 | 0.6% |
| Monte Rosa Therapeutics Inc(GLUE) | Common | 61225M102 | $33.7M | 4,325,000 | 0.5% |
| Mersana Therapeutics Inc | Common | 59045L106 | $31.0M | 7,550,000 | 0.5% |
| Ultragenyx Pharmaceutical Inc(RARE) | Common | 90400D108 | $30.1M | 750,000 | 0.4% |
| Marinus Pharmaceuticals Inc(MRNS*) | Common | 56854Q200 | $21.7M | 3,150,000 | 0.3% |
| Aadi Biosciences Inc(WHWK) | Common | 00032Q104 | $20.6M | 2,849,402 | 0.3% |
| Design Therapeutics Inc(DSGN) | Common | 25056L103 | $20.2M | 3,500,000 | 0.3% |
| Verrica Pharmaceuticals Inc | Common | 92511W108 | $17.2M | 2,650,000 | 0.3% |
| PMV Pharmaceuticals Inc(PMVP) | Common | 69353Y103 | $14.6M | 3,060,000 | 0.2% |
| Amylyx Pharmaceuticals Inc(AMLX) | Common | 03237H101 | $13.9M | 473,100 | 0.2% |
| Fennec Pharmaceuticals Inc(FENC) | Common | 31447P100 | $10.0M | 1,200,000 | 0.1% |
| Seres Therapeutics Inc(MCRB1EUR) | Common | 81750R102 | $7.3M | 1,295,000 | 0.1% |
| Tango Therapeutics Inc(TNGX) | Common | 87583X109 | $6.5M | 1,640,000 | 0.1% |
| IO Biotech Inc(IOBT) | Common | 449778109 | $3.8M | 2,055,883 | 0.1% |
| Sarepta Therapeutics Inc(SRPT)Call | Common | 803607100 | $3.7M | 250,000 | 0.1% |
| Iveric BIO Inc(OPHTEUR)Call | Common | 46583P102 | $1.8M | 875,000 | 0.0% |
| Spdr Series Trust - S&P Biotech(XBI)Call | ETF | 78464A870 | $180.0K | 1,500,000 | 0.0% |